Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Perrigo Company PLC

PRGO ✗ NOT COMPLIANT ☆ Track — members

NYSE · Healthcare · Pharmaceuticals ·

USA Small Cap Analyst: HOLD

Last Close

$13.04

▲ +1.64%

Market Cap $1.81B · Vol 724.64K

Key Metrics

P/E Ratio

N/A

FWD: 5.62

Market Cap

$1.81B

Small Cap

Div Yield

9.04%

Quarterly dividend

EPS Growth

-21.14%

YoY

RSI (14)

75.35

Momentum

Beta

0.61

vs Market

52W High

$24.61

47.00% below

52W Low

$9.23

41.28% above

Volume

724.64K

Avg 919.49K

P/B

0.65

Price-to-book

ROE

10.52%

Return on equity

Free Float

99.57%

Public shares

Shariah Compliance8 STANDARDS

✗ Perrigo Company PLC (PRGO) stock is currently not Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See which standards it fails, the exact ratios behind the verdict, and halal alternatives. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does PRGO pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+1.56%

+31.72%

+20.30%

-10.32%

YTD

-6.32%

-43.38%

-66.46%

-68.16%

Financials & Valuation

TTM · Annual

Total Revenue	$4.25B
Net Income	$-1,402,300,000.00
Revenue Growth (YoY)	-3.17%
Gross Margin	35.14%
Operating Margin	7.35%
Net Profit Margin	-32.97%
ROE	10.52%
ROA · ROIC	-14.28% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	5.62
PEG Ratio	N/A
P/S	0.45
P/B	0.65
P/FCF	13.29
EPS Growth	-21.14%
Outstanding Shares	138.77M

Technical Indicators

50-Day SMA	$10.84
200-Day SMA	$12.40
RSI (14)	75.35
Beta	0.61
52-Week High	$24.61
52-Week Low	$9.23

Volume Today	724.64K
Avg Daily Volume (30D)	919.49K
Relative Volume	0.79x
Volatility (10D)	105.62
Volatility (30D)	75.85
Free Float	99.57%

Analyst Consensus

HOLD

Current Price $13.04

Mean Target $15.50

52W Low$9.23 52W High$24.61

Current

Target

$9.23 $24.61

Current Analyst target

+18.87% upside potential · 5 analysts

Identifiers

ExchangeNYSE

FIGIBBG001S704D8

ISINIE00BGH1M568

CountryIreland

Sub-IndustryPharmaceuticals (NEC)

Earnings DateNov 5, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LLY Eli Lilly and Co -2.39% JNJ Johnson & Johnson -0.66% ABBV Abbvie Inc -0.54% NVS Novartis AG -0.55% NOVN.S Novartis AG -1.05%

Company Profile

Perrigo Company plc is a pure-play self-care company. The Company provides health and wellness solutions. Its segments include Self Care, Specialty Care, and Infant Formula. Self Care comprises Upper Respiratory, Digestive Health, Pain & Sleep and Healthy Lifestyle product categories globally. Specialty Care comprises our Women's Health and Skin Health product categories globally. Infant Formula comprises the Infant Formula product category, which includes nutritional products designed to meet the dietary needs of infants. It provides a store-branded private label provider of self-care products in many categories, including upper respiratory, healthy lifestyle and women's health, along with brands including Opill and Mederma. Its Europe portfolio consists primarily of brands, including Compeed, ellaOne, Solpadeine, Jungle Formula, and ACO. Its upper respiratory products include Nasonex 24HR Energy, Mucus DM, All Day Allergy, Nighttime Cold & Flu, and Allergy Relief.